AU2001245295A1 - Methods and compositions for the identification, assessment, prevention and therapy of human cancers - Google Patents
Methods and compositions for the identification, assessment, prevention and therapy of human cancersInfo
- Publication number
- AU2001245295A1 AU2001245295A1 AU2001245295A AU4529501A AU2001245295A1 AU 2001245295 A1 AU2001245295 A1 AU 2001245295A1 AU 2001245295 A AU2001245295 A AU 2001245295A AU 4529501 A AU4529501 A AU 4529501A AU 2001245295 A1 AU2001245295 A1 AU 2001245295A1
- Authority
- AU
- Australia
- Prior art keywords
- assessment
- therapy
- prevention
- compositions
- identification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18326500P | 2000-02-17 | 2000-02-17 | |
| US60/183,265 | 2000-02-17 | ||
| PCT/US2001/005301 WO2001061050A2 (en) | 2000-02-17 | 2001-02-16 | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001245295A1 true AU2001245295A1 (en) | 2001-08-27 |
Family
ID=22672111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001245295A Abandoned AU2001245295A1 (en) | 2000-02-17 | 2001-02-16 | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20020120004A1 (en) |
| AU (1) | AU2001245295A1 (en) |
| WO (1) | WO2001061050A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080050836A1 (en) * | 1998-05-01 | 2008-02-28 | Isabelle Guyon | Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia |
| US7434305B2 (en) * | 2000-11-28 | 2008-10-14 | Knowles Electronics, Llc. | Method of manufacturing a microphone |
| US20090215058A1 (en) * | 2001-01-24 | 2009-08-27 | Health Discovery Corporation | Methods for screening, predicting and monitoring prostate cancer |
| US20090226915A1 (en) * | 2001-01-24 | 2009-09-10 | Health Discovery Corporation | Methods for Screening, Predicting and Monitoring Prostate Cancer |
| US20090215024A1 (en) * | 2001-01-24 | 2009-08-27 | Health Discovery Corporation | Biomarkers upregulated in prostate cancer |
| JP2006505256A (en) * | 2002-05-17 | 2006-02-16 | ベイラー カレッジ オブ メディスン | Different gene expression patterns to predict the chemical sensitivity and chemical resistance of docetaxel |
| EP1564305A3 (en) * | 2004-02-12 | 2005-08-24 | Institut Curie | Means for detecting and treating cancer cells resistant to therapeutic agents |
| EP1828917A4 (en) * | 2004-11-12 | 2012-04-25 | Health Discovery Corp | Biomarkers for screening, predicting, and monitoring prostate disease |
| CN102747140A (en) * | 2004-12-08 | 2012-10-24 | 安万特药物公司 | Method for measuring resistance or sensitivity to docetaxel |
| WO2011135459A2 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
| US10392667B2 (en) | 2013-06-07 | 2019-08-27 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
| US20180087113A1 (en) | 2016-09-27 | 2018-03-29 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2018202878A1 (en) | 2017-05-16 | 2018-12-06 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2019200325A1 (en) | 2018-01-31 | 2019-08-15 | Liplasome Pharma Aps | Methods for treating cancer and predicting drug responsiveness in cancer patients |
| US20210222252A1 (en) | 2018-05-15 | 2021-07-22 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| US10835531B1 (en) | 2019-06-18 | 2020-11-17 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2021212305A1 (en) | 2020-01-31 | 2022-08-11 | Allarity Therapeutics Europe ApS | Methods for predicting ixabepilone responsiveness in cancer patients |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137371A0 (en) * | 1998-01-26 | 2001-07-24 | Schering Ag | Gene expression methods for screening compounds |
| WO1999065928A2 (en) * | 1998-06-19 | 1999-12-23 | Genzyme Corporation | Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues |
-
2001
- 2001-02-16 WO PCT/US2001/005301 patent/WO2001061050A2/en not_active Ceased
- 2001-02-16 AU AU2001245295A patent/AU2001245295A1/en not_active Abandoned
- 2001-02-16 US US09/788,099 patent/US20020120004A1/en not_active Abandoned
-
2002
- 2002-10-16 US US10/272,111 patent/US20030129629A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001061050A3 (en) | 2003-02-27 |
| US20020120004A1 (en) | 2002-08-29 |
| WO2001061050A2 (en) | 2001-08-23 |
| US20030129629A1 (en) | 2003-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU6147401A (en) | Compositions and methods for the treatment of cancer | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002219782A1 (en) | Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2001245295A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU7701100A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
| AU2002257033A1 (en) | Agents and methods for the prevention of initial onset and recurrence of existing cancers | |
| AU2001238493A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002241720A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |